• Home >
  • News >
  • Nagpur Consumer Commission Says Disclosed Alcohol Use Did Not Justify Life Claim Rejection

Nagpur Consumer Commission Says Disclosed Alcohol Use Did Not Justify Life Claim Rejection

life insurance claim rejected non-disclosure

An insurer cannot reject a claim over a drinking habit the buyer had already disclosed. That, in short, is what a consumer commission in Nagpur has ruled, ordering Edelweiss Tokio Life Insurance to pay a widow a claim of ₹50 lakh with interest after it repudiated her late husband’s policy on the ground of non-disclosure of his alcohol use. The District Consumer Disputes Redressal Commission, Nagpur, held the rejection to be a deficiency in service, in an order passed in August 2026.

How the Claim was Rejected

The complainant’s husband bought the Edelweiss Tokio Life policy in April 2021 and died suddenly on 26 January 2023. His death came less than two years into the policy, the window in which insurers scrutinise claims most closely. When the widow filed her claim, the insurer rejected it, cancelled the policy, and sent her a premium refund cheque of ₹18,713 in September 2023. She then approached the consumer commission, seeking both the claim and compensation for mental harassment. The insurer defended the rejection by arguing that the deceased had concealed a history of chronic alcoholism, hypertension and diabetes mellitus, breaching the principle of utmost good faith, or uberrima fides, on which an insurance contract rests.

What the Insurer’s Own Records Showed

The commission’s finding turned on the insurer’s own paperwork. The medical examination form submitted on 20 May 2021, before the policy was issued, clearly recorded that the insured consumed “whisky of 90 ml twice in a month since 15 years”. The pre-policy medical examination carried out by the company’s own panel doctor made no mention of either hypertension or diabetes. Since the drinking had been set down in writing at the outset and the two conditions were never flagged by the insurer’s doctor, the ground of concealment did not hold. The forum also referred to Supreme Court decisions concerning hypertension and diabetes as lifestyle-related conditions. In this case, however, the key point was that the insurer’s own pre-policy medical examination had not recorded either condition, undermining the insurer’s later allegation of concealment.

What the Commission Ordered

Even though it was clearly mentioned before the policy was taken that the complainant’s husband consumed alcohol, the Commission held that the insurer had caused a deficiency in service by rejecting a legally payable claim. It directed Edelweiss Tokio Life to pay the claim amount of ₹50 lakh along with 9% annual interest calculated from 30 September 2023. The insurer was also ordered to pay ₹10,000 as compensation for physical and mental harassment and a further ₹10,000 towards litigation costs. The interest, running from the date around which the claim ought to have been settled, means the final payout runs well above the ₹50 lakh sum assured.

What it Signals for Policy Buyers

The ruling reinforces the importance of whether the information allegedly concealed was actually disclosed during the proposal or medical stage. For policy buyers, the proposal form and pre-policy medical records can become crucial evidence when an insurer later alleges non-disclosure. For buyers, the practical lesson is that the proposal form and the pre-policy medical report are the documents that decide a disputed claim later, which is why keeping a copy of both matters. This is where independent guidance helps, and MyRupia, which holds no insurer stake and works on paid consultations rather than commissions, helps buyers get those disclosures recorded correctly so a genuine claim cannot be unwound years later.

Disclaimer: This MyRupia article is for informational purposes only and is based on publicly available government, regulatory and industry sources. It should not be treated as investment, financial, tax, insurance, or legal advice. Information, examples, market data, and expert views mentioned in the article may change over time and should not be considered a recommendation to buy, sell, invest in, or surrender any financial product. Readers should evaluate their individual circumstances and consult a qualified financial professional before making decisions.

All Categories
Scroll to Top